Barbara A. da Silva

Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen

Todd T. Brown, Grace A. McComsey, Martin King et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 314 citations

Medicine, Infectious Diseases, Pharmacotherapy +17

Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4 ⁺ T Cells

Martyn A. French, Martin King, Jean M. Tschampa et al. · The Journal of Infectious Diseases · 2009 · 239 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A 96‐Week Comparison of Lopinavir‐Ritonavir Combination Therapy Followed by Lopinavir‐Ritonavir Monotherapy versus Efavirenz Combination Therapy

D. William Cameron, Barbara A. da Silva, José Ramón Arribas et al. · The Journal of Infectious Diseases · 2008 · 111 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks

Joseph Gathe, Barbara A. da Silva, Daniel E. Cohen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 86 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Functional Properties of Leptin Receptor Isoforms Containing the Gln→Pro Extracellular Domain Mutation of the Fatty Rat*

Barbara A. da Silva, Christian Bjørbæk, Shigeo Uotani et al. · Endocrinology · 1998 · 77 citations · Full text

Life Sciences, Molecular Biology, Physiology +17